Double pump for a failing heart: can two devices boost recovery?
NCT ID NCT03431467
Summary
This study tested if adding a small heart pump (Impella CP) to a standard life-support machine (VA-ECMO) helps people with severe cardiogenic shock. The goal was to see if this combined approach helps the heart rest and recover better, allowing patients to survive without needing a transplant or long-term support devices. The trial was stopped early and only enrolled 17 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital of The University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.